Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next-generation sequencing identifies rare variants associated with Noonan syndrome
Peng‐Chieh Chen, Jiani C. Yin, Hui-Wen Yu, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 31, pp. 11473-11478
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Nancy Ratner, Shyra J. Miller
Nature reviews. Cancer (2015) Vol. 15, Iss. 5, pp. 290-301
Open Access | Times Cited: 419
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
Michael Krauthammer, Yong Kong, Antonella Bacchiocchi, et al.
Nature Genetics (2015) Vol. 47, Iss. 9, pp. 996-1002
Open Access | Times Cited: 381
Recent advances in RASopathies
Yoko Aoki, Tetsuya Niihori, Shinichi Inoue, et al.
Journal of Human Genetics (2015) Vol. 61, Iss. 1, pp. 33-39
Open Access | Times Cited: 336
Rare variants inSOS2andLZTR1are associated with Noonan syndrome
Guilherme Lopes Yamamoto, Meire Aguena, Monika Goś, et al.
Journal of Medical Genetics (2015) Vol. 52, Iss. 6, pp. 413-421
Open Access | Times Cited: 216
The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway
Mylène Tajan, Romain Paccoud, Sophie Branka, et al.
Endocrine Reviews (2018) Vol. 39, Iss. 5, pp. 676-700
Open Access | Times Cited: 196
Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants
Jennifer J. Johnston, Jasper J. van der Smagt, Jill A. Rosenfeld, et al.
Genetics in Medicine (2018) Vol. 20, Iss. 10, pp. 1175-1185
Open Access | Times Cited: 186
Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination
Mikhail Steklov, Silvia Pandolfi, Maria Francesca Baietti, et al.
Science (2018) Vol. 362, Iss. 6419, pp. 1177-1182
Open Access | Times Cited: 176
The RASopathies: from pathogenetics to therapeutics
Katie E. Hebron, Edjay R. Hernandez, Marielle E. Yohe
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 117
MECHANISMS IN ENDOCRINOLOGY: Novel genetic causes of short stature
Jan M. Wit, Wilma Oostdijk, Monique Losekoot, et al.
European Journal of Endocrinology (2015) Vol. 174, Iss. 4, pp. R145-R173
Open Access | Times Cited: 163
Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk
Anita Villani, Mary‐Louise C. Greer, Jennifer M. Kalish, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 12, pp. e83-e90
Open Access | Times Cited: 144
Pathogenetics of the RASopathies
William E. Tidyman, Katherine A. Rauen
Human Molecular Genetics (2016) Vol. 25, Iss. R2, pp. R123-R132
Open Access | Times Cited: 112
Expansion of the RASopathies
William E. Tidyman, Katherine A. Rauen
Current Genetic Medicine Reports (2016) Vol. 4, Iss. 3, pp. 57-64
Open Access | Times Cited: 98
Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation
Karim Kouz, Christina Lißewski, Stephanie Spranger, et al.
Genetics in Medicine (2016) Vol. 18, Iss. 12, pp. 1226-1234
Open Access | Times Cited: 94
The molecular genetics of RASopathies: An update on novel disease genes and new disorders
Marco Tartaglia, Yoko Aoki, Bruce D. Gelb
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 425-439
Open Access | Times Cited: 43
Spectrum of mutations and genotype–phenotype analysis in Noonan syndrome patients with RIT1 mutations
Masako Yaoita, Tetsuya Niihori, Seiji Mizuno, et al.
Human Genetics (2015) Vol. 135, Iss. 2, pp. 209-222
Closed Access | Times Cited: 90
RASopathies: unraveling mechanisms with animal models
Granton A. Jindal, Yogesh Goyal, Rebecca D. Burdine, et al.
Disease Models & Mechanisms (2015) Vol. 8, Iss. 8, pp. 769-782
Open Access | Times Cited: 86
Assessing the gene–disease association of 19 genes with the RASopathies using the ClinGen gene curation framework
Andrew R. Grant, Brandon J. Cushman, Hélène Cavé, et al.
Human Mutation (2018) Vol. 39, Iss. 11, pp. 1485-1493
Open Access | Times Cited: 83
Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome
Viviana Cordeddu, Jiani C. Yin, Cecilia Gunnarsson, et al.
Human Mutation (2015) Vol. 36, Iss. 11, pp. 1080-1087
Open Access | Times Cited: 76
Noonan syndrome-causing genes
Ihssane El Bouchikhi, Khadija Belhassan, Fatima Zohra Moufid, et al.
International Journal of Pediatrics and Adolescent Medicine (2016) Vol. 3, Iss. 4, pp. 133-142
Open Access | Times Cited: 71
Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1–PPP1CB complexes
Ikumi Umeki, Tetsuya Niihori, Taiki Abe, et al.
Human Genetics (2018) Vol. 138, Iss. 1, pp. 21-35
Closed Access | Times Cited: 71
Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome–Associated Cardiomyopathy
Ulrich Hanses, Mandy Kleinsorge, Lennart Roos, et al.
Circulation (2020) Vol. 142, Iss. 11, pp. 1059-1076
Open Access | Times Cited: 66
Clinical Presentation and Natural History of Hypertrophic Cardiomyopathy in RASopathies
Giulio Calcagni, Rachele Adorisio, Simone Martinelli, et al.
Heart Failure Clinics (2018) Vol. 14, Iss. 2, pp. 225-235
Closed Access | Times Cited: 64
Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome
Yline Capri, Elisabetta Flex, Oliver H.F. Krumbach, et al.
The American Journal of Human Genetics (2019) Vol. 104, Iss. 6, pp. 1223-1232
Open Access | Times Cited: 64
Inducible Pluripotent Stem Cell–Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1 -Associated Noonan Syndrome
Fabrice Jaffré, Clint L. Miller, Anne Schänzer, et al.
Circulation (2019) Vol. 140, Iss. 3, pp. 207-224
Open Access | Times Cited: 63
Cardiovascular disease in Noonan syndrome
Mary Ella Pierpont, M. Cristina Digilio
Current Opinion in Pediatrics (2018) Vol. 30, Iss. 5, pp. 601-608
Closed Access | Times Cited: 59
Page 1 - Next Page

Scroll to top